SIRT6 Antibody (YA078)
(Synonyms: SIR2L6, SIRT6, NAD-dependent protein deacylase sirtuin-6, NAD-dependent protein deacetylase sirtuin-6, Protein mono-ADP-ribosyltransferase sirtuin-6, Regulatory protein SIR2 homolog 6, SIR2-like protein 6, hSIRT6)Based on 1 publication(s) in Google Scholar
SIRT6 Antibody (YA078) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SIRT6.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, ICC/IF, IHC-P, FC
-
Reactivity :
Human, Mouse
-
Formulation:
Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) SIRT6 Antibody (YA078)
More
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
FC
FC: Flow Cytometry
|
|---|---|---|---|---|
| Dilution Ratio | 1:500 | 1:50-1:200 | 1:50-1:500 | 1:50-1:100 |
Product Details
SIRT6 Antibody (YA078) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SIRT6.
-
Host Rabbit
-
Clonality Recombinant,Monoclonal
-
Species ReactivityHuman, Mouse
-
Observed Molecular WeightObserved band size: 39 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 39 kDa
Entrez Gene: 51548 Human ; 50721 Mouse ; 299638 Rat
SwissProt: Q8N6T7 Human ; P59941 Mouse ;
OMIM: 606211 Human
Synthetic peptide corresponding to Human SIRT6.AA range:306-355.
Endogenous
Protein A affinity purified.
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 1*TBS (pH7.4), 0.05% BSA and 40% Glycerol. Preservative: 0.05% Sodium Azide.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Naunyn Schmiedebergs Arch Pharmacol
Gastrodin prevents myocardial injury in sleep-deprived mice by suppressing ferroptosis through SIRT6. [Abstract]2024 Nov;397(11):9111-9121. PMID: 38896272
Verification Images
-
Western blot analysis of extracts from MCF-7(lane 2(20μg) , NIH/3T3(lane 3(20μg) ,C2C12(lane 4(20μg)and HepG2( lane 5(20μg) using SIRT6 Antibody (HY-P80322). Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody ( 1/500) and Loading control antibody (Beta Actin, HY-P80993,1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HY-P8001,1/10,000) was used for 1 hour at room temperature.
-
Immunohistochemical analysis of paraffin-embedded human Breast Cancer tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Immunohistochemical analysis of paraffin-embedded human Breast Cancer tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Immunohistochemical analysis of paraffin-embedded human Colon cancer tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Immunohistochemical analysis of paraffin-embedded human Cervical Cancer tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Immunohistochemical analysis of paraffin-embedded human Cervical Cancer tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Immunohistochemical analysis of paraffin-embedded human Testis tissue using SIRT6 antibody was performed. The section was pretreated using high-temperature and high-pressure mediated EDTA antigen retrieval buffer (pH 9.0), for 5 minutes. The tissues were incubated with primary antibody (HY-P80322, 1:200 dilution) at room temperature for 60 minutes. Detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. The tissues were counterstained with hematoxylin and mounted with neutral balsam mounting medium.
-
Flow cytometric analysis of 1X106 HeLa cells labeling SIRT6 Antibody (HY-P80322, red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then stained with the primary antibody at 1/50 dilution for an hour at 4℃. AF488-conjugated Goat Anti-Rabbit IgG H&L (HY-P8002) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Rabbit IgG Isotype Control (HY-P80879, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
-
Immunocytochemistry analysis of Hela cells labeling SIRT6 with SIRT6 Antibody (HY-P80322) at 1/100 dilution . Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with quick block buffer for 10 minutes at room temperature. Cells were then incubated with SIRT6 Antibody (HY-P80322) at 1/100 dilution in quick block buffer overnight at 4 ℃. AF488-conjugated Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
-
Immunocytochemistry analysis of Hela cells labeling SIRT6 with SIRT6 Antibody (HY-P80322) at 1/200 dilution . Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with quick block buffer for 10 minutes at room temperature. Cells were then incubated with SIRT6 Antibody (HY-P80322) at 1/200 dilution in quick block buffer overnight at 4 ℃. AF488-conjugated Goat Anti-Rabbit IgG H&L(HY-P8002, Green) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. The Nuclear counterstain was DAPI (Blue).
Background
-
Function
SIRT6 is a nuclear NAD+-dependent sirtuin that functions as a deacetylase, deacylase, and mono-ADP-ribosyltransferase, thereby maintaining chromatin integrity, DNA repair capacity, telomere stability, and metabolic homeostasis[1][2]. Mechanistically, SIRT6 regulates multiple signaling and transcriptional programs involved in aging, cellular stress responses, glucose and lipid metabolism, inflammation, and genome maintenance, placing it at the intersection of epigenetic regulation and cellular adaptation[2][5][3]. Through its effects on DNA damage repair, chromosome maintenance, and metabolic control, SIRT6 contributes to the preservation of cellular function and resistance to age-associated dysfunction[5][3]. In disease contexts, altered SIRT6 activity has been linked to cancer, cardiovascular disease, diabetes, and neurodegenerative disorders, while experimental studies demonstrate that SIRT6 deficiency induces mitochondrial dysfunction, oxidative stress, and broad transcriptional changes associated with brain aging and neurodegeneration[2][4]. Compared with related sirtuin isoforms, SIRT6 is distinguished by its predominant chromatin-associated functions and its combined deacetylase, deacylase, and mono-ADP-ribosyltransferase activities that directly couple NAD+ sensing to epigenetic and genome-stability pathways[1][5]. For experimental applications, increasing attention has focused on small-molecule SIRT6 modulators, including both activators and inhibitors, which provide useful tools for mechanistic studies and evaluation of SIRT6-dependent pathways in aging, metabolism, cancer, and neurodegenerative disease models[2][6].
-
Subcellular Localization
Nucleus; Chromosome; Chromosome, telomere; Endoplasmic reticulum
-
Expression
Induction:Down-regulated in a number of cancers, such as pancreatic cancer or colon carcinomas (PubMed:23217706) . Post-transcriptionally regulated by miR-766 (PubMed:23653361) . Expression is post-transcriptionally repressed by miR-122 (PubMed:26748705) -
Subunit
Homodimer; binds to nucleosomes and DNA ends as a homodimer (PubMed:31995034, PubMed:32538779). Interacts with RELA; interferes with RELA binding to target DNA (PubMed:19135889). Interacts with SMARCA5; promoting recruitment of SMARCA5/SNF2H to double-strand breaks (DSBs) sites (PubMed:23911928). Interacts with the mTORC2 complex; preventing the ability of SIRT6 to deacetylate FOXO1. Interacts with the CLOCK-BMAL1 complex; recruited by the CLOCK-BMAL1 complex to regulate expression of clock-controlled genes. Interacts with CSNK2A2; preventing CSNK2A2 localization to the nucleus (By similarity)
-
SwissProt ID
-
Synonyms
SIR2L6, SIRT6, NAD-dependent protein deacylase sirtuin-6, NAD-dependent protein deacetylase sirtuin-6, Protein mono-ADP-ribosyltransferase sirtuin-6, Regulatory protein SIR2 homolog 6, SIR2-like protein 6, hSIRT6
-
Research Field
Epigenetics and Nuclear Signaling
Documentation
-
Data Sheet (262 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
User Guide for Antibodies (1077 KB)
[1]. Uniprotkb.
[2]. Chen RR, et al. SIRT6 in health and diseases: From molecular mechanisms to therapeutic prospects. Pharmacol Res. 2025 Nov;221:107984. [Content Brief]
[3]. SIRT6 gene information from NCBI.
[4]. Smirnov D, et al. SIRT6 is a key regulator of mitochondrial function in the brain. Cell Death Dis. 2023 Jan 18;14(1):35. [Content Brief]
[5]. Li Y, et al. SIRT6 Widely Regulates Aging, Immunity, and Cancer. Front Oncol. 2022;12:861334.